List view / Grid view

ReNeuron Group



ReNeuron Group publishes stroke clinical data

4 August 2016 | By Niamh Louise Marriott, Digital Content Producer

The PISCES I study was the first clinical trial of ReNeuron’s CTX cell therapy candidate for patients with motor disability as a consequence of ischaemic stroke. The data, collated over two years relates to the eleven stroke patients treated in the study...